Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
03/2003
03/19/2003EP1035831B1 Use of carboxylic acid to stabilize or improve epidermal synthesized ceramide
03/19/2003EP0758245B1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori
03/19/2003EP0662825B1 Multi-vitamin and mineral supplement for pregnant women
03/19/2003CN1404385A Method of using a beverage composition for treating dental erosion
03/19/2003CN1404382A Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
03/19/2003CN1403142A Suppository for treating piles and other anorectal diseases and its prepn
03/19/2003CN1403139A Externally applied Chinese medicine for treating osteoarthropathy and its prepn process
03/19/2003CN1403135A Medicine for treating diabetes and its complication
03/19/2003CN1403128A Chinese medicine for treating deep ulcer and bedsore
03/19/2003CN1403118A Medicine for treating prostatosis and its prepn
03/19/2003CN1403117A Compound vagina-cleaning flavescent sophora lotion
03/19/2003CN1403114A Production process of cancer-eliminating pearl powder
03/19/2003CN1403111A Fracture-setting medicine
03/19/2003CN1403101A Fracture-setting silky fowl ointment and its prepn
03/19/2003CN1403093A Oral vanadium replenishing agent with bimetallic oxide as carrier and its prepn and usage
03/19/2003CN1403092A Nutritive medicine for remitting or treating pregnant woman's vomiting
03/19/2003CN1103230C External use ointment for treating pigmented naevus, senile plaque, freckle and plane warts and its preparing method
03/19/2003CN1103226C Medicine for treating burn and scald
03/19/2003CN1103223C Chinese herbal medicine preparation for treating cholecystitis
03/19/2003CN1103222C External use medicinal liquid for treating psoriasis
03/19/2003CN1103220C Medicinal composition for treating optic atrophy
03/18/2003US6534540 Combination and method of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor
03/18/2003US6534086 Composition and method for treatment of inflammation and pain in mammals
03/18/2003US6533767 Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
03/18/2003CA2298093C An anti-cancer therapy agent of arsenic hexoxide (as4o6) of a natural chemical substance and its pharmaceutical composition
03/18/2003CA2239420C Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
03/13/2003WO2003020642A2 Precipitated aragonite and a process for producing it
03/13/2003WO2003020272A1 Compositions and methods for the treatment of cancer
03/13/2003WO2003020262A2 Use of polyunsaturated fatty acids for intra-arterial injection for selectively occluding blood supplies to neoplasias
03/13/2003WO2003020259A2 Combinations of dmxaa and other anti-cancer agents
03/13/2003WO2003020240A2 Therapeutic agent delivery tampon
03/13/2003WO2003020227A1 Compositions and methods relating to prevention of chemotherapy-induced alopecia
03/13/2003WO2003020221A2 Method of treating cancerous disease
03/13/2003WO2003020211A2 Nitric oxide generation
03/13/2003WO2003020208A2 Treatment of neurologic hemorrhage
03/13/2003WO2002098416A3 Antineoplastic combinations
03/13/2003WO2002096447A3 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor
03/13/2003WO2002060459A3 Use of iodide salt as an aphrodisiac
03/13/2003WO2002047662A3 Antibiotic/benzoyl peroxide dispenser
03/13/2003WO2002034293A3 Use of citric acid as antimicrobial agent or enhancer or as anticancer agent
03/13/2003WO2002034069A3 Supplement and method for nutritional supplementation of calcium, including a prophylactic motility agent
03/13/2003US20030050287 Mixture of 2-hydroxyestrone and a substantially less amount of 17-beta estradiol
03/13/2003US20030050253 The synergistic combination of a loop diuretic and a cardiac glycoside is useful in the treatment of DNA viral infections such as Herpes virus infections
03/13/2003US20030050250 Administering an aromatic dipeptide derivative with a chemotherapeutic agent to treat tumor metastasis, solid tumor growth, angiogenesis and other neoplasia diseases
03/13/2003US20030049713 Evaluating modulator of kallikrein generation; obtain prekallikrein mixture, incubate with kininogen, phosphate and zinc ions and modulator, monitor adjustment in generation of kallikrein
03/13/2003US20030049331 Mixture of loop diuretics and lithium; contact lenses
03/13/2003US20030049205 That undergoes/interferes with cytochrome P450 metabolism, using d-threo-methylphenidate; side effect reduction of drug-drug interaction toxicity; tricyclic antidepressants or selective serotonin reuptake inhibitors
03/13/2003CA2833997A1 Method and apparatus for nitric oxide generation
03/13/2003CA2459891A1 Method and apparatus for nitric oxide generation
03/13/2003CA2458459A1 Anti-cancer combinations
03/12/2003EP1291019A1 Biologically active agents and drugs
03/12/2003EP1289923A2 Epithelial cell cancer drug
03/12/2003EP1289604A2 Compositions containing hexitol and an antiproliferative agent
03/12/2003EP1289557A2 Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor
03/12/2003EP1289510A2 Compositions, kits, and methods for promoting defined health benefits
03/12/2003EP1289509A2 Compositions containing naphthaquinone and an antiproliferative agent
03/12/2003EP1289496A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
03/12/2003EP1289477A2 Compositions for treating tooth and/or bone tissue
03/12/2003EP1196034B1 Antiparasitic formulation
03/12/2003EP1131100B1 Therapeutic compositions for metabolic bone disorders or bone metastases comprising a photosensitizer and a bisphosphonate
03/12/2003EP1083895B1 Compositons comprising sclareol or scareolide for the treatment of microbial infections
03/12/2003EP0914138B1 Complex preparations characterised by a betain content
03/12/2003CN1401378A Chinese medicine composition for treating colitis
03/12/2003CN1401371A 'Shenhuaxiaokecha' tea and preparing method thereof
03/12/2003CN1401370A Extracted herbal medicine for treating chicken infectious bursa of Fabricius
03/12/2003CN1401366A Chinese medicinal herbs ointment and preparing method thereof
03/12/2003CN1401361A Medicine for treating aphtha
03/12/2003CN1401357A External applied medical ointment for treating piles
03/12/2003CN1401329A Oral Selenium supplement agent using bimetallic oxide as carrier, and preparing process and use method thereof
03/12/2003CN1401317A Use of bismuth subgallate in suppressing formation of nitrogen oxide synthetase
03/12/2003CN1102852C Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs
03/12/2003CN1102851C Plasma like solution
03/11/2003US6531512 Method of treating cancer in patients having a deficiency in p53 tumor suppressor gene
03/11/2003CA2239422C Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders
03/06/2003WO2003018595A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003WO2003018496A1 Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof
03/06/2003WO2003018495A1 Water-insoluble, antimicrobial silicate glass and use thereof
03/06/2003WO2003018036A1 Composition for detection and/or treatment of lesions & tumours
03/06/2003WO2003018035A1 Pharmaceutical preparation for treating wounds
03/06/2003WO2003018034A1 Antacid and laxative tablets
03/06/2003WO2003017996A1 Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
03/06/2003WO2003017993A1 Photoreactive compounds and compositions
03/06/2003WO2003017961A1 Antimicrobial oral composition and method of use
03/06/2003WO2003017769A1 Antimicrobial agent
03/06/2003WO2002066516A3 Antibodies that bind both bcma and taci
03/06/2003WO2002058692A9 Halogenated composition, method for preparing same and uses thereof
03/06/2003WO2002055106A3 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
03/06/2003WO2002012325A3 Suppressor gene
03/06/2003US20030045829 Therapeutic agent delivery tampon
03/06/2003US20030045494 Synthetic oligonucleotides complementary to nucleic acids encoding epidermal growth factor
03/06/2003US20030044472 Dimethylaminoethanol (DMAE), omega 3-fatty acids, betaine, oligomeric proanthocyanidins (OPC), folic acid, vitamins A, C,E,B12,B6,B5, as well as minerals calcium, magnesium, zinc and selenium
03/06/2003US20030044446 A multilayered film comprising a first, water-soluble adhesive layer to be placed in contact with a mucosal surface and a second, water-erodible non-adhesive backing layer that controls residence time; drug delivery from mouth
03/06/2003US20030044360 Blending before applying; containing carbamide peroxide
03/06/2003CA2458622A1 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003CA2458476A1 Photoreactive compounds and compositions
03/06/2003CA2457488A1 Antimicrobial agent
03/05/2003EP1288305A2 Plasma prekallikrein activation and kallikrein production assay
03/05/2003EP1286676A1 Bismuth compounds for the treatment and prevention of mucositis
03/05/2003EP1286675A2 Method for increasing the antioxidative potential of selenium-containing aqueous solutions
03/05/2003EP1286667A2 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases
1 ... 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 ... 563